• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

±èö¿ë

±èö¿ë
¼¼ºÎÀü°ø
¼ÒÈ­±â¾Ï, µÎ°æºÎ¾Ï, À¯¹æ¾Ï, Á¾¾çÇÐ

±èö¿ë ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
¹æ»ç¼±Á¾¾çÇаú
¿ÀÈÄ
¿ÀÀü
-
Á¾ÀÏ
- - ¼ÒÈ­±â¾Ï, µÎ°æºÎ¾Ï, À¯¹æ¾Ï, Á¾¾çÇÐ

±èö¿ë ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1979 .03  ~  1985 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ Á¹¾÷, Çлç
  • 1986 .03  ~  1988 .02  :  °í·Á´ëÇб³ Àǰú´ëÇпø Á¹¾÷, ¼®»ç
  • 1993 .03  ~  1996 .02  :  °í·Á´ëÇб³ Àǰú´ëÇпø Á¹¾÷, ¹Ú»ç

°æ·Â

more
  • 1990 .03  ~  1992 .04  :  ±¹±º¼öµµÅëÇÕº´¿ø Ä¡·á¹æ»ç¼­¼±°ú°úÀå
  • 1999 .03  ~  2000 .02  :  ij³ª´Ù ¹êÄí¹ö ¾Ï¼¾ÅÍ ¿¬¼ö
  • 2001 .11  ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú °úÀå
  • 2002 .04  ~   :  °í·Á´ëÇб³ Àǰú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç ÁÖÀÓ±³¼ö
  • 2006 .08  ~  2007 .10  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÇлýºÎÇÐÀå
  • 2007 .10  ~  2008 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ Ãѹ«ºÎÇÐÀå
  • 2008 .02  ~  2008 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÇÐÀå(±ÇÇÑ´ëÇà)
  • 2011 .03  ~   :  ±ÝÀ¶°¨µ¶¿ø ÀÚ¹®À§¿ø

ÇÐȸȰµ¿

more
  • 1993 .11  ~  1997 .10  :  ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Ãѹ«
  • 2004 .11  ~  2007 .10  :  ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Àü¹®ÀÇ °í½ÃÀÌ»ç
  • 2007 .11  ~  2011 .09  :  ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ ¹«ÀÓ¼Ò ÀÌ»ç
  • 2011 .10  ~  2013 .09  :  ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ À±¸®ÀÌ»ç

³í¹®

more
  • [SCI] (Protective effect of triphala on radiation induced acute intestinal mucosal damage in sprague dawley rats)
  • [SCI] Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies
  • [SCI] Analysis of Output Factors with Various Detectors in Small-field Electron-beam Radiotherapy
  • [±¹¿Ü³í¹®] (The extent and serial pattern of interfractional variation in patients with whole pelvic irradiation: a study using a kilovoltage orthogonal on-board imager)
  • [±¹³»³í¹®] ³úÇϼöü Á¾¾çÀÇ ¹æ»ç¼±Ä¡·á(Radiotherapy for pituitary adenomas: long-term outcome and complications)
  • [±¹³»³í¹®] ÀÌÂ÷¿ø¹æ»ç¼±Ä¡·á¸¦ ½ÃÇàÇÑ ÄÚÀÎµÎ¾Ï È¯ÀÚÀÇ Àå±â ÃßÀû °á°ú ¹× ¿¹ÈÄÀÎÀÚ ºÐ¼®
  • [±¹³»³í¹®] ÀýÁ¦ ºÒ°¡´ÉÇÑ ÃéÀå¾Ï¿¡¼­ ¼ö¼úÁß ¹æ»ç¼±Ä¡·áÀÇ Àû¿ë
  • [±¹¿Ü³í¹®] (Comparison of linac-based fractionated stereotactic radiotherapy and tomotherapy treatment plans for intra-cranial tumors)
  • [±¹³»³í¹®] °í¾Ç¼ºµµ ½Å°æ¾Æ±³Á¾ÀÇ ¼ö¼ú ÈÄ ¹æ»ç¼± Ä¡·á ¼ºÀû°ú ¿¹ÈÄÀÎÀÚ ºÐ¼®
  • [SCI] (Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea)
  • [SCI] (Analysis of the Dosimetric Characteristics of Normoxic Polymer Gel by Magnetic Resonance Images)
  • [SCI] (Estimate of the Real-Time Respiratory Simulation System in CyberKnife Image-Guided Radiosurgery)
  • [SCI] (Dose Response Characteristics in Polymer Gel for the Composition Ratio)
  • [SCI] (Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study)
  • [±¹³»³í¹®] Clinical Factors Related to Suspected Second Primary Lung Cancer Development in Patients with Head and Neck Cancer
  • [SCI] (Determination of target motion by using a respiration monitoring mask for 4-D radiotherapy)
  • [±¹³»³í¹®] Á¶±â¼º¹®¾Ï¿¡¼­ ¹æ»ç¼±Ä¡·á ½ÇÆÐÀÇ À§ÇèÀÎÀÚ¿Í ±¸Á¦¼ö¼úÀÇ Ä¡·á°á°ú
  • [SCI] (Development of a novel normoxic polymer gel dosimeter (TENOMAG))
  • [±¹³»³í¹®] ÀÌÀü¿¡ ¿ÜºÎ¹æ»ç¼±Ä¡·á¸¦ ¹ÞÀº Æó¾Ï ȯÀÚ¿¡¼­ ±â°üÁö³» ±ÙÁ¢Ä¡·áÀÇ °í½ÄÀû È¿°ú
  • [±¹³»³í¹®] °í·ÉÀÇ ºñ¼Ò¼¼Æ÷¼ºÆó¾Ï ȯÀÚÀÇ ¹æ»ç¼± ¹× º´¿ëÄ¡·á¿¡ ´ëÇÑ È¿°ú Æò°¡
  • [±¹¿Ü³í¹®] (Rectum dose analysis employing a multi-purpose brachytherapy phantom)
  • [±¹³»³í¹®] (Real-time Body Motion Tracking using the Couch Based Computer-controlled Motion Phantom(CBMP) and Ultrasonic Sensor: A Feasibility Study)
  • [±¹³»³í¹®] (Real-time body surface motion tracking using the couch based computer-controlled motion phantom (SBMP) and US sensors: A feasibility study)
  • [±¹³»³í¹®] ¹æ»ç¼±Ä¡·á·Î ÀÎÇÑ ÅëÁõ ¹× ¾Ï¼ºÅëÁõ¿¡ ´ëÇÑ µà·ÎÁ¦½ÄÀÇ È¿°ú: ´Ù±â°ü¿¬±¸
  • [±¹¿Ü³í¹®] (Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract)
  • [±¹³»³í¹®] ´ÜÀÏ ±¹¼Ò¹æ»ç¼± Á¶»ç ÈÄ ¹é¼­ ´ë³ú ÇÇÁúÀÇ Ãʱ޼º±â º¯È­¿¡ ´ëÇÑ ¿¬±¸
  • [±¹³»³í¹®] µ¿ ÆÒÅÒ°ú ÃÊÀ½ÆÄ ¼¾¼­¸¦ ÀÌ¿ëÇÑ È£Èí¿îµ¿ Á¶Àý ¹æ»ç¼±Ä¡·á ±â¼ú °³¹ß
  • [±¹¿Ü³í¹®] (Upregulation of VEGF and FGF2 in normal rat brain after experimental Intraoperative radiation therapy)
  • [±¹¿Ü³í¹®] (Development of respiratory motion reduction device system (RMRDs) for radiotherapy in moving tumors)
  • [±¹¿Ü³í¹®] (Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix)
  • [±¹³»³í¹®] (Endobronchial Brachytherapy of Advanced Non-small Cell Lung Carcinoma)
  • [±¹³»³í¹®] (´ÜÀÏ °í¼±·®¹æ»ç¼±Á¶»ç ÈÄ ¹ß»ýÇÑ ¹é¼­ÀÇ Ã´¼ö¼¼Æ÷ ÀÚ¸ê»ç¿¡ ´ëÇÑ NimodopineÀÇ È¿°ú)
  • [SCI] (VALUE OF EXTERNAL IRRADIATION FOR LOCALLY ADVANCED PAPILLARY THYROID CANCER)
  • [±¹³»³í¹®] ÀڱðæºÎ¾ÏÀÇ ¹æ»ç¼±Ä¡·á ¹× ¹æ»ç¼±Ç×¾ÏÈ­ÇÐ º´¿ëÄ¡·á¿¡ µû¸¥ À¯ÀüÀÚ¹ßÇö Á¶Àý¾ç»ó
  • [±¹³»³í¹®] ¹æ»ç¼±Ä¡·á Pattern of Care Study °³¹ßÀ» À§ÇÑ 2002³â Çѱ¹ ¹æ»ç¼±Á¾¾çÇаú Àü¹®ÀǵéÀÇ Á÷Àå¾Ï ¹æ»ç¼±Ä¡·á ¿øÄ¢ Á¶»ç¿¬±¸
  • [±¹³»³í¹®] »ó¾Çµ¿ ÆíÆò¼¼Æ÷¾ÏÁ¾¿¡¼­ÀÇ ¹æ»ç¼±Ä¡·á
  • [±¹³»³í¹®] ¼Ó¹ß¼º ´ãµµ Á¾¾ç¿¡ ÀÇÇÑ ´ãµµÆó¼â¿¡¼­ °í¼±·®·ü °ü³» ±ÙÁ¢Ä¡·á
  • [±¹³»³í¹®] ÀڱðæºÎ¾ÏÀÇ °í¼±·®À² ±ÙÁ¢Ä¡·á: ºÐÇÒ¼±·®¿¡ µû¸¥ °á°ú ºñ±³
  • [±¹³»³í¹®] ³úÁ¾¾çÀÇ ¼ö¼úÁß ¹æ»ç¼±Ä¡·á
  • [±¹¿Ü³í¹®] (Intraoperative radiation therapy as an adjunctive therapy for huge and highly vascular parasagittal meningiomas)
  • [±¹³»³í¹®] ÀڱðæºÎ¾Ï ȯÀÚÀÇ ¿¹ÈÄÀÎÀÚ¿¡ °üÇÑ ºÐ¼®
  • [±¹³»³í¹®] (TLD Dosimetry in HDR Intracavitary Brachytherapy)
  • [±¹³»³í¹®] (Performance Evaluation of an Electrometer for Quality Control and Dosimetry in Radiation Therapy)
  • [±¹³»³í¹®] ºÒ¿ÏÀü ÀýÁ¦µÈ ¼ö¸·Á¾¿¡¼­ ¼ö¼úÈÄ ¹æ»ç¼±Ä¡·áÀÇ ¿ªÇÒ
  • [±¹³»³í¹®] ±¹¼Ò ÁøÇ༺ ºñ¼Ò¼¼Æ÷ Æó¾Ï¿¡ ´ëÇÑ cisplatin°ú °æ±¸ etoposide¸¦ »ç¿ëÇÑ ¹æ»ç¼± È­ÇÐ µ¿½Ã¿ä¹ýÀÇ Ä¡·áÈ¿°ú

ÃÖÁ¾¼öÁ¤ÀÏ : 2021.03.16